CORPORATE STEWARDSHIP REPORTS
For more than 100 years Grifols has looked to the future, committed to continued, sustainable and ethical growth. We are convinced that only a job well-done, with integrity, rigor and honesty, will allow us to truly create value for patients and society beyond financial performance.
Sustainable Development Goals
Learn about Grifols' efforts to achieve Sustainable Development Goals adopted by the United Nations.
Grifols' commitment to our donors
Plasma is an essential raw material in the manufacture of plasma-derived therapies, which are used to treat and prevent potentially life-threatening diseases and conditions for patients around the world. Plasma donations are the only means possible to produce plasma-derived medicines and enhance the quality of life of patients who require them.
Grifols' Social Value
Grifols completed its first-time ever project to measure the social value created by Grifols' U.S. donation centers. It followed the SROI methodology which enabled us to unveil the social value created for donors, patients and local communities where these centers are based.
Socio-economic impact that Grifols has on it principal markets in terms of wealth generation and job creation
Our sustainability efforts are internationally recognized
In 2020, Grifols was recognized by the Dow Jones Sustainability Index (DJSI) as one of the world's most sustainable companies and included in the DJSI Europe.
In 2020, Grifols was included on the Euronext Vigeo Europe 120 and Euronext Vigeo Eurozone 120 indices, based on the evaluation of Vigeo Eiris, the prestigious rating agency that assesses the performance of the most sustainable listed companies in Europe.
Since 2018, Grifols has been included in the FTSE4Good Index, which independently rates companies on their environmental, social and corporate governance performance.
For the first time, Grifols is included in the 2021 Bloomberg Gender-Equality Index (GEI), demonstrating Grifols' commitment to addressing gender inequality.
In 2020, Grifols improves its Carbon Disclosure Project (CDP) rating, which assesses corporate strategy and performance related to climate change, reaching an "A-" management rating.
Codes and Policies
Review our codes of conduct, corporate policies.
Internal Codes & Regulations
Historical annual reports
Annual report 2018
Annual report 2017
Annual report 2016
This information is aimed exclusively at authorized healthcare professionals to prescribe or supply medicinal products and its correct interpretation requires specialized training.
Are you a healthcare professional?